Panic & Overwhelm

Panic & Overwhelm: A Nutritional and Natural-Health Reference

1. Definition and Conceptual Overview

Panic, in its clinical form, refers to panic disorder — a condition separate from individual panic attacks, although characterized by recurrent, unexpected panic attacks defined by the DSM as "an abrupt surge of intense fear or discomfort" reaching a peak within minutes. Panic disorder is an often chronic and impairing human anxiety syndrome, which frequently results in serious psychiatric and medical comorbidities.

Overwhelm, while not a formal DSM diagnostic category, is widely recognized in psychological and physiological literature as a distinct stress state. Overwhelm is a stress response that occurs when a person perceives that the demands placed on them exceed their emotional, cognitive, or physical resources, often leading to mental fog, irritability, avoidance, and difficulty making decisions. Any physical or psychological stimuli that disrupt homeostasis result in a stress response; the stimuli are called stressors, and physiological and behavioral changes in response to exposure to stressors constitute the stress response, mediated through a complex interplay of nervous, endocrine, and immune mechanisms, activating the sympathetic-adreno-medullar (SAM) axis, the hypothalamic-pituitary-adrenal (HPA) axis, and the immune system.

Panic and overwhelm are closely related but distinguishable phenomena. Panic disorder is unique among anxiety disorders in that the emotional symptoms — such as fear and anxiety — associated with panic are strongly linked to body sensations indicative of threats to physiological homeostasis. Overwhelm, in contrast, is more broadly understood as a capacity problem: overwhelm happens when the demands on a person's system — tasks, responsibilities, emotions, expectations — exceed what they feel equipped to handle; it is not just having a lot to do, but the feeling that there is too much and not enough capacity to meet it all.

2. Presentation and Symptomatology

2.1 Panic Attacks and Panic Disorder

Panic attacks are defined as "an abrupt surge of intense fear or discomfort" reaching a peak within minutes, with four or more of a specific set of physical symptoms: palpitations, pounding heart or accelerated heart rate, sweating, trembling or shaking, sensations of shortness of breath or smothering, feelings of choking, chest pain or discomfort, nausea or abdominal distress, dizziness, unsteadiness, light-headedness or faint, chills or heat sensations, paresthesias (numbness or tingling sensations), derealization or depersonalization, fear of losing control or "going crazy," and fear of dying.

To meet DSM-5-TR criteria for panic disorder, panic attacks must be associated with longer than one month of subsequent persistent worry about having another attack or consequences of the attack, or significant maladaptive behavioral changes related to the attack. Other symptoms or signs may include headache, cold hands, diarrhea, insomnia, fatigue, intrusive thoughts, and ruminations.

Panic attacks can occur alongside other anxiety, mood, psychotic, substance use, and even medical disorders, and are associated with increased symptom severity of various disorders, suicidal ideation and behavior, and diminished treatment response in patients with concomitant anxiety and mental disorders.

2.2 Overwhelm State

When stress becomes chronic or overwhelming, the nervous system can struggle to keep up, leaving people feeling anxious, emotionally exhausted, disconnected, reactive, or even completely shut down. When the nervous system becomes dysregulated, the body may stay stuck in a prolonged state of stress, hypervigilance, or shutdown, which over time can impact emotional, physical, and cognitive functioning.

3. Body Systems Involved

3.1 The Fear Network and Brain Regions

Challenge studies with a variety of panicogenic agents operating by diverse pharmacologic mechanisms have suggested a network model of panic involving dysregulation of multiple neuronal systems. Functional imaging studies confirm preclinical investigations of the anatomical basis of anxiety and provide further evidence for a network of related brain regions mediating the genesis of anxious and fearful behaviors, including panic attacks.

Functional neuroimaging has shown activation of the insula and upper brain stem (including the periaqueductal gray, or PAG), as well as deactivation of the anterior cingulate cortex (ACC) during experimental panic attacks. Voxel-based morphometric analysis has shown a grey matter volume increase in the insula and upper brain stem, and a decrease in the ACC in panic patients at rest compared to healthy controls. The insula and ACC detect interoceptive stimuli, which are overestimated by panic patients, and it is suggested that these brain areas and the PAG are involved in the pathophysiology of panic disorder.

3.2 Autonomic and Endocrine Systems

Neuroendocrinological results indicate that the hypothalamic-pituitary-adrenal (HPA) axis is activated by anticipatory anxiety, but not by panic attack itself, nor by electrical stimulation of the rat PAG. The stress response is mediated through complex interplay of nervous, endocrine, and immune mechanisms, activating the SAM axis, HPA axis, and the immune system; it is adaptive to prepare the body to handle internal or external environmental challenges.

3.3 Neuroimmune Mechanisms

Accumulating evidence suggests that neuroimmune mediators play a role in fear and panic-associated disorders, although this has not been systematically investigated, and current understanding of the role of immune mechanisms in the etiology and maintenance of panic disorder remains limited. Immune signaling can contribute to maladaptive body-to-brain communication and conditioned fear relevant to spontaneous and conditioned symptoms of panic disorder.

3.4 Cardiovascular System

The emotional, behavioral, and physiological responses occurring during panic attacks — such as fear, anxiety, hyperventilation, and cardiovascular responses — are evoked in an effort to restore physiological homeostasis. The heightened autonomic response causes an increase in heart rate and blood pressure.

3.5 The Gut–Brain Axis

The gut microbiota and the brain are interconnected in a bidirectional relationship, as research on the microbiome–gut–brain axis shows; significant evidence links anxiety and depression disorders to the community of microbes that live in the gastrointestinal system.

4. Epidemiology

Women are 2–3 times more likely to be affected by panic disorder than men. Anxiety disorders are among the major contributors to the worldwide burden of disease. Anxiety disorders are highly comorbid with each other and with major depressive disorder.

5. Contributing and Associated Factors

5.1 Genetic and Temperamental Vulnerability

Genetic analyses are consistent with a heritable predisposition, or "panic diathesis," that confers an increased susceptibility to pharmacologic challenge, even in subjects with no overt history of panic disorder. Recent evidence for a neurobiological basis of panic disorder highlights risk factors such as genetic vulnerability, chronic stress, and temperament.

In a recent candidate gene meta-analytic study of 23 common variants of 20 candidate genes — including genes involved in the serotonin, norepinephrine, dopamine, and neuropeptide systems — COMT rs4680 and TMEM132D rs7370927 were significantly associated with panic diagnosis.

5.2 Chronic Stress and Early Life Adversity

Vulnerability factors such as genetic predisposition, early life adversity, chronic illness, physiological state (including dehydration), or other psychiatric disorder diagnoses are associated with innate sensitivity to homeostatic triggers; these homeostatic triggers lead to a heightened state of alarm, the activation of threat response systems, and a panic attack.

5.3 Comorbid Psychiatric and Medical Conditions

Anxiety disorders are highly comorbid with each other and with major depressive disorder; as syndromes, anxiety and mood disorders share many symptoms, and several treatments are effective for both.

5.4 Interoceptive Sensitivity

The insula and the ACC detect interoceptive stimuli, which are overestimated by panic patients. This overestimation of bodily signals — a heightened sensitivity to normal physiological sensations such as heart rate fluctuations or breathing changes — is a central cognitive-biological feature of panic disorder recognized across neuroimaging and clinical research.

5.5 Nutritional Deficiencies

Micronutrients such as zinc, magnesium, selenium, iron, and vitamins B-6, B-12, D, E, and folate are deficient in those who have depression or are at greater risk of developing depression and anxiety. Vitamin B6 acts as a limiting cofactor in the synthesis of neurotransmitters such as GABA, dopamine, serotonin, and norepinephrine; vitamin B9 (folate) deficiency can alter DNA stability, hinder neuronal differentiation and repair, and affect the levels of monoamine neurotransmitters by regulating the synthesis of tetrahydrobiopterin.

5.6 Gut Microbiome Dysbiosis

Nutritional research indicates that diets rich in antioxidants can reduce anxiety, while pro-inflammatory diets including high-sugar and high-processed food can heighten anxiety and cause neurochemical changes; these effects could be mediated by the gut microbiome, which is strongly interconnected with both diet and anxiety, with healthy- and Western-like dietary patterns differentially affecting gut bacteria.

6. Nutrients Studied in Relation to Panic and Overwhelm

6.1 Magnesium

Traditional Use: Magnesium-rich foods and preparations have a longstanding place in traditional dietary approaches to nervous system support. Herbs such as passionflower, kava, St. John's wort and valerian root, as well as the amino acid lysine and the cation magnesium, have been used for centuries in folk and traditional medicine to calm the mind and positively enhance mood.

Scientific Evidence: Magnesium is popular for the treatment of anxiety and insomnia, and preclinical studies support associations between magnesium status, sleep quality, and symptoms of anxiety; however, the extent to which these claims are evidence-based is unclear.

Four studies analyzed the concentration of magnesium in patients suffering from anxiety disorders; three of them reported no significant differences in magnesium serum levels in generalized anxiety disorder, panic disorder, and anxiety symptoms during a major depressive episode.

For anxiety, trials suggest a possible anxiolytic effect, often with combination preparations, but evidence remains scarce and heterogeneous. Given the generally positive results across studies, the preponderance of preclinical evidence, and minimal side effects, supplemental magnesium is likely useful in the treatment of mild anxiety and insomnia, particularly in those with low magnesium status at baseline. Larger, randomized clinical trials are needed to confirm efficacy and establish optimal forms and dosages.

One specific clinical trial noted that a 2-week intervention with 248 mg of elemental magnesium per day can lead to clinical improvement in patients with anxiety and depressive disorders. In two other papers, a reduced Hamilton Anxiety Rating Scale (HAM-A) score in depressed patients correlated with higher levels of magnesium, and beneficial levels of magnesium were found in stressed patients.

Evidence strength: Preliminary to moderate; heterogeneous results in clinical trials; strongest effect seen in those with documented deficiency or low baseline intake.

6.2 Omega-3 Fatty Acids

Traditional and Dietary Context: Omega-3 fatty acids from fish and marine sources have been a dietary staple across many traditional cultures. Their relevance to mental health has gained considerable scientific attention.

Scientific Evidence: A meta-analysis of 19 clinical trials found that omega-3 fatty acids demonstrated stronger beneficial effects in participants with clinical levels of anxiety compared to sub-clinical levels of anxiety; however, the authors found no significant treatment effect for anxiety symptoms in participants without specific clinical conditions.

Diets rich in omega-3 fatty acids, such as those including fish oil, can enhance beneficial microbial communities, bolster gut barrier function, and decrease levels of circulating LPS, thus mitigating systemic inflammation. Associations have been reported between reduced anxiety and higher intake of omega-3 fatty acids, vegetables, fruits, micronutrients, and alpha-lipoic acid.

Evidence strength: Moderate; meta-analytic support for clinically anxious populations; mechanisms involve anti-inflammatory and gut microbiome pathways; larger, well-controlled trials needed.

6.3 B Vitamins (B6, B9/Folate, B12)

Scientific Evidence: Vitamin B6 acts as a limiting cofactor in the synthesis of neurotransmitters such as GABA, dopamine, serotonin, and norepinephrine; vitamin B9 (folate) deficiency can alter DNA stability, hinder neuronal differentiation and repair, and affect monoamine neurotransmitter levels by regulating tetrahydrobiopterin synthesis. These neurochemical roles are well-established biochemically, though direct interventional evidence specifically for panic disorder is limited. Deficiencies in these vitamins are consistently associated with increased anxiety risk in observational literature.

Evidence strength: Mechanistically well-supported; interventional evidence for panic specifically is limited; observational studies link deficiency to increased anxiety risk.

6.4 Vitamin D

Scientific Evidence: Omega-3 fatty acids, turmeric (curcumin), and vitamin D are thought to have a therapeutic effect on anxiety. No significant results were reported for a multivitamin complex nor vitamin E, C, and zinc alone, and there were inconsistent effects for magnesium; however, ameliorating effects were reported for beta-carotene and iron-fortified micronutrient supplementation. Vitamin D deficiency is common in the general population, and its role in mood regulation is an active research area. Large-scale RCT evidence specifically for panic disorder and vitamin D supplementation remains limited.

Evidence strength: Preliminary; observational associations exist; direct intervention trials for panic disorder are lacking.

6.5 L-Theanine

Traditional Use: L-theanine is an amino acid found naturally in green tea (Camellia sinensis), which has been consumed in East Asian traditional culture for centuries as a calming beverage.

Scientific Evidence: A comprehensive systematic review searching six electronic databases focused on randomized controlled trials of L-theanine supplementation on mental health outcomes identified 11 studies from six countries, covering a range of disorders including schizophrenia, ADHD, OCD, major depressive disorder, sleep disorders, and generalized anxiety disorder. L-theanine has been proposed to modulate GABA receptor activity and increase alpha brain wave activity, though mechanistic evidence is primarily from preclinical studies.

Evidence strength: Preliminary; a small number of RCTs in anxiety populations suggest modest benefit; direct evidence in panic disorder specifically is very limited.

7. Herbs and Natural Ingredients Studied in Relation to Panic and Overwhelm

7.1 Lavender (Lavandula angustifolia) — Silexan

Traditional Use: Lavender has been used for centuries across European and Mediterranean herbal traditions as a nervine — administered as teas, aromatics, tinctures, or topically — for calming the nervous system, relieving restlessness, and supporting sleep. Lavandula angustifolia, generally termed lavender, has been exploited for years as a therapy for distinct ailments and can act as an antispasmodic, analgesic, hypotensive, antiseptic, antimicrobial, and tonic agent promoting overall health and vitality.

Scientific Evidence: The most robust clinical evidence for lavender concerns a standardized oral extract called Silexan. Silexan is a proprietary essential oil manufactured from Lavandula angustifolia flowers by steam distillation that complies with the monograph Lavender oil of the European Pharmacopoeia.

Silexan taken orally at a daily dose of 80 mg for 10 weeks was significantly superior to placebo in reducing psychic and somatic symptoms of anxiety and was as effective as 0.5 mg/day lorazepam and 20 mg/day paroxetine. Meta-analyses support its significant anxiety-relieving impact over placebo and comparable efficacy to lorazepam, but without sedation or withdrawal.

A meta-analysis determined a mean value difference favouring silexan 80 mg/day of 2.93 points on the HAMA total score compared to placebo (p < 0.001); superiority of lavender oil over placebo was somewhat more pronounced for the psychic anxiety subscale; treatment effects were most pronounced for anxious mood, tension, and insomnia.

Proposed mechanisms include interaction with the nervous and endocrine systems to modulate pathophysiology and improve mood and behavior, and modulation of GABA receptors to relax neurons, spare more serotonin in synapses, and channelize neurotransmitters through distinct signaling cascades.

Evidence strength: Moderate-to-strong for oral Silexan in subsyndromal and generalized anxiety; multiple randomized, placebo-controlled trials; evidence is not specific to panic disorder; most trials sponsored by the manufacturer.

7.2 Kava (Piper methysticum)

Traditional Use: Kava is a plant native to the Pacific Islands and has been used ceremonially and medicinally in Pacific Island cultures for centuries, consumed as a water-based drink prepared from the root. Its traditional uses include promoting relaxation, reducing anxiety, and facilitating social bonding.

Scientific Evidence: Kava extract may produce moderately beneficial effects on anxiety symptoms; however, the use of kava supplements has been linked to a risk of severe liver damage. Strong evidence exists for the use of herbal supplements containing extracts of passionflower or kava as treatments for anxiety symptoms and disorders.

Neurochemical effects of kava include reversible inhibition of monoamine oxidase B, inhibition of cyclo-oxygenase, reduced neuronal reuptake of dopamine and prefrontal cortex noradrenaline; this noradrenergic effect differentiates the central bio-behavioural effects of kava from those of alcohol and benzodiazepines, while the combination of GABA modulation and increased noradrenergic activation contributes to its characteristic effects.

Evidence strength: Moderate for generalized anxiety disorder; hepatotoxicity risk is a significant safety concern documented in the literature and noted by regulatory bodies; evidence for panic disorder specifically is limited.

7.3 Passionflower (Passiflora incarnata)

Traditional Use: Passionflower has longstanding use in North American indigenous and subsequently European herbal traditions as a sedative and nervine. It was used traditionally as a tea or tincture for restlessness, nervous tension, and insomnia.

Scientific Evidence: A small amount of research suggests that passionflower might help to reduce anxiety and anxiety before a dental procedure, but conclusions are not definite; passionflower is considered to be safe when used orally. Strong evidence from a systematic review exists for the use of herbal supplements containing passionflower extracts as treatments for anxiety symptoms and disorders.

Evidence strength: Preliminary to moderate; limited number of small clinical trials; generally well-tolerated; no specific high-quality evidence in panic disorder.

7.4 Valerian (Valeriana officinalis)

Traditional Use: Valerian root has been used in European traditional medicine since at least the time of ancient Greece and Rome. It was historically prepared as teas and tinctures to promote sleep, calm the nerves, and address restlessness.

Scientific Evidence: The NCCIH states that there is insufficient evidence to determine whether valerian can alleviate anxiety or depression, although studies suggest that valerian is generally safe. There is not enough evidence to allow any conclusions about whether valerian is helpful for anxiety; research suggests that valerian is generally safe for short-term use by most adults, with the safety of long-term use unknown.

Evidence strength: Insufficient per NCCIH assessment; existing trials are small and methodologically heterogeneous; more rigorous trials needed.

7.5 Ashwagandha (Withania somnifera)

Traditional Use: Ashwagandha is a well-established herb in Ayurvedic medicine, increasingly researched for its adaptogenic properties and regulatory roles in neuroimmune processes. It has been used for millennia in Indian Ayurvedic practice as a rasayana (rejuvenating tonic), typically prepared as a powder with warm milk or as a decoction.

Scientific Evidence: A comprehensive review integrates mechanistic, preclinical, and clinical evidence on ashwagandha's immunomodulatory and psychiatric activities; its bioactive withanolides, sitoindosides, and alkaloids modulate the HPA axis, inhibit NF-κB, induce Nrf2 activation, and affect GABAergic signaling; clinical trials with standardized ashwagandha extracts have shown reductions in stress-related biomarkers, along with improvements in cognitive performance, sleep quality, and mood parameters.

A meta-analysis of 15 studies with a combined sample size of 873 patients examined ashwagandha's effects on cortisol, stress, and anxiety. The findings indicate that ashwagandha formulations have beneficial effects on stress and anxiety; adverse effects associated with ashwagandha are limited, although further information is required to determine its long-term safety profile.

The review emphasizes methodological shortcomings, such as heterogeneity in extract preparation, small sample sizes, variability in endpoints, and possible funding-related biases; subsequent studies should emphasize standardized extract formulations and long-term, multicenter randomized trials with biomarker monitoring.

Evidence strength: Moderate for stress and generalized anxiety outcomes; direct evidence in panic disorder is limited; evidence quality is improving but methodological limitations remain.

7.6 L-Lysine and L-Arginine (Amino Acid Combinations)

Traditional and Dietary Context: Both L-lysine and L-arginine are essential or conditionally essential amino acids obtained from dietary protein. Their use in combination specifically for anxiety reduction is a more recent nutritional intervention.

Scientific Evidence: Strong evidence exists for the use of combinations of L-lysine and L-arginine as treatments for anxiety symptoms and disorders, based on a systematic review of herbal and nutritional supplement trials. These amino acids are proposed to act on serotonin receptors and partially inhibit the stress-hormone response, though the human trial evidence base remains small.

Evidence strength: Preliminary to moderate; limited number of trials; recognized in a systematic review as having strong evidence relative to other supplements, though the absolute number of high-quality trials is small.

8. Dietary Patterns and Lifestyle Factors

8.1 Dietary Patterns

Associations have been reported between lower levels of anxiety symptoms or disorder prevalence and "healthy" dietary patterns, including a higher intake of vegetables, fruits, micronutrients, omega-3 fatty acids, alpha-lipoic acid, and omega-9 fatty acids, and between increased anxiety and a higher intake of sugar and refined carbohydrates, and an inadequate intake of tryptophan and protein.

Results of a randomized pilot trial suggest that anxiety levels decreased during a complex dietary intervention; as purported by the fields of nutritional psychiatry, the Mediterranean dietary pattern may improve mental health due to positive changes in micronutrient and macronutrient availability, gut microbiome, inflammation, and glycemic control.

8.2 The Gut Microbiome and Probiotics

Epidemiology research has demonstrated the protective benefits of modified diets, fish and omega-3 fatty acid intake, probiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, and 5-hydroxytryptophan regulation against anxiety and depression.

Research looking at diet, gut microbiome, and anxiety simultaneously is scarce, and a few studies that have investigated microbiome-anxiety specific associations have reported contradictory results.

8.3 Caffeine

Caffeine has a robust effect on subjective anxiety in panic disorder patients as well as healthy controls, with both groups experiencing more anxiety following caffeine; in the case of panicogenic effects of caffeine, all studies pointed in the same direction of increased risk of panic attacks in patients.

People who experience panic attacks may want to be cautious about excessive caffeine consumption; in a review of research involving more than 235 people, more than 50% of participants had panic attacks following caffeine consumption, the majority of whom (98%) had a prior history of panic attacks, and none of the participants who received a placebo had a panic attack; all consumption amounts were more than 400 mg.

Evidence status: High caffeine intake is consistently associated with worsened anxiety and increased risk of panic attacks in those with panic disorder; a systematic review and meta-analysis supports this association; individual sensitivity varies.

8.4 Alcohol

Alcohol can make individuals edgy and interfere with normal sleep, which can cause anxiety levels to rise. Alcohol is also recognized in the clinical literature as producing rebound anxiety and autonomic arousal during withdrawal, which can precipitate or worsen panic symptoms.

8.5 Exercise and Physical Activity

Available evidence suggests that engaging in physical activity protects against anxiety symptoms and disorders. Aerobic exercise was effective in the treatment of raised anxiety compared to waiting-list control groups (effect size −0.41, 95% CI = −0.70 to −0.12); high intensity exercise programmes showed greater effects than low intensity programmes.

For panic disorder specifically, there is clear evidence indicating that regular exercise programs (at least two 20-minute sessions per week for at least 6 weeks) reduce panic-related symptoms; regular exercise is also effective in improving global anxiety measures and depression. For panic disorder, exercise appears to reduce anxiety symptoms, though it is less effective than antidepressant medication in one RCT; exercise combined with antidepressant medication improved Clinical Global Impression outcomes; and exercise combined with occupational therapy and lifestyle changes reduced Beck Anxiety Inventory outcomes.

8.6 Sleep

Sleep disruption is both a symptom and a contributing factor in panic and overwhelm. Preclinical studies support associations between magnesium status, sleep quality, and symptoms of anxiety. Chronic sleep insufficiency activates the HPA axis and sympathetic nervous system, compounding the physiological vulnerability to panic and overwhelm; this relationship is documented across the stress physiology and anxiety literature, though direct sleep intervention trials in panic disorder are not yet a well-developed research area.

8.7 Inflammation and Oxidative Stress

A complementary approach to medicating symptoms of anxiety is to address the underlying metabolic pathologies associated with mental illnesses, which may be achieved through nutritional interventions. Pathological correlates of anxiety disorders include the possible roles of microbiome dysbiosis and inflammation, suggesting anxiety can be considered in part a metabolic disease.

9. Summary of Evidence Landscape

The scientific literature on nutritional and natural-health factors in panic and overwhelm is growing but remains characterized by significant heterogeneity. The most well-evidenced nutritional area is the broader relationship between dietary pattern quality, inflammatory status, gut microbiome diversity, and anxiety risk. Among specific interventions, oral lavender oil (Silexan) has the strongest clinical trial base, with multiple randomized, placebo-controlled trials confirming anxiolytic efficacy comparable to low-dose benzodiazepines and SSRIs in generalized anxiety and subsyndromal anxiety. Kava has demonstrated moderate efficacy in human trials but carries a safety concern regarding hepatotoxicity. Magnesium, omega-3 fatty acids, and ashwagandha have accumulating evidence supporting modest benefits, particularly in individuals with documented deficiency or clinical levels of anxiety. Passionflower, valerian, and L-theanine have preliminary positive signals but insufficient high-quality trial data to draw firm conclusions. For lifestyle factors, exercise and dietary quality modification have robust evidential support. High caffeine intake is well-documented to exacerbate panic attacks. Direct, high-quality RCT evidence specifically targeting panic disorder with nutritional interventions remains an underexplored area requiring dedicated future research.

References

• Coplan JD, Gorman JM. The biological basis of panic disorder. PubMed.
• Bhatt S, Bhatt DL. Neuroimmune mechanisms in fear and panic pathophysiology. PubMed PMC (2022).
• Shin LM, Liberzon I. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. PubMed (2009).
• Graeff FG, Del-Ben CM. Neurobiology of panic disorder: from animal models to brain neuroimaging. PubMed (2008).
• Dresler T et al. The Neurobiology of Panic: A Chronic Stress Disorder. PMC (2020).
• Cackovic C et al. Panic Disorder. StatPearls, NCBI Bookshelf.
• Chu B et al. Physiology, Stress Reaction. StatPearls, NCBI Bookshelf.
• Medscape. Panic Disorder: Practice Essentials, Background, Etiology.
• National Institute of Mental Health (NIMH). Panic Disorder Statistics.
• Botturi A et al. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review. PMC (2020).
• Noah L et al. Examining the Effects of Supplemental Magnesium on Self-Reported Anxiety and Sleep Quality: A Systematic Review. PMC / Cureus (2024).
• Rajizadeh A et al. Magnesium supplementation beneficially affects depression in adults: a systematic review and meta-analysis of randomized clinical trials. PMC (2024).
• National Center for Complementary and Integrative Health (NCCIH). Anxiety and Complementary Health Approaches.
• NCCIH Clinical Digest. Anxiety and Complementary Health Approaches: What the Science Says.
• Lakhan SE, Vieira KF. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. PMC (2010).
• Pratte MA et al. Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis. PMC (2025).
• Pahuja M et al. Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects. PMC (2025).
• Pratte MA et al. Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. PubMed (2024).
• Ghazizadeh J et al. A Comprehensive Review on Anxiolytic Effect of Lavandula Angustifolia Mill. in Clinical Studies. PMC (2025).
• Möller HJ et al. Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials. PMC (2023).
• Kasper S et al. Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data. PMC (2025).
• Savage K et al. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial. PMC (2015).
• Sarris J et al. The effects of L-theanine supplementation on outcomes of patients with mental disorders: a systematic review. PMC (2024).
• Chen H et al. Mechanisms of microbiota-gut-brain axis communication in anxiety disorders. Frontiers in Neuroscience (2024).
• Aucoin M et al. Nutrition as Metabolic Treatment for Anxiety. Frontiers in Psychiatry (2021).
• Chahwan B et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. PMC (2023).
• Barone M et al. Diet quality and anxiety: a critical overview with focus on the gut microbiome. PMC / Frontiers in Nutrition (2024).
• Opie R et al. Dietary counseling plus omega-3 supplementation in the treatment of generalized anxiety disorder: results of a randomized wait-list controlled pilot trial (EASe-GAD Trial). Nutritional Neuroscience (2024).
• Klevebrant L, Frick A. Effects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis. ScienceDirect (2022).
• Liu C et al. Caffeine intake and anxiety: a meta-analysis. PMC / Frontiers in Psychology (2024).
• UCLA Health. Is caffeine making you anxious? 5 things to know.
• Pearce M et al. Physical Activity and Anxiety: A Systematic Review and Meta-analysis of Prospective Cohort Studies. American Journal of Preventive Medicine (2019).
• Ramos-Sanchez CP et al. Can regular physical exercise be a treatment for panic disorder? A systematic review. PubMed (2022).
• Stonerock GL et al. Exercise as Treatment for Anxiety: Systematic Review and Analysis. PMC (2015).
• Stubbs B et al. Exercise in the treatment of clinical anxiety in general practice: a systematic review and meta-analysis. PMC (2017).